- call +1-201-465-4211
- email sales@mrinsights.biz
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
Scope of the Report:
This report studies the Motion Sickness Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Motion Sickness Treatment market by product type and applications/end industries.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
The global Motion Sickness Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Motion Sickness Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anticholinergic
Antihistamines
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Motion Sickness Treatment Market Overview
1.1 Product Overview and Scope of Motion Sickness Treatment
1.2 Classification of Motion Sickness Treatment by Types
1.2.1 Global Motion Sickness Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Motion Sickness Treatment Revenue Market Share by Types in 2017
1.2.3 Anticholinergic
1.2.4 Antihistamines
1.2.5 Others
1.3 Global Motion Sickness Treatment Market by Application
1.3.1 Global Motion Sickness Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Motion Sickness Treatment Market by Regions
1.4.1 Global Motion Sickness Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Motion Sickness Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Motion Sickness Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Motion Sickness Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Motion Sickness Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Motion Sickness Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Motion Sickness Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Motion Sickness Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Perrigo Company
2.2.1 Business Overview
2.2.2 Motion Sickness Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Perrigo Company Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Prestige Brands
2.3.1 Business Overview
2.3.2 Motion Sickness Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Prestige Brands Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 WellSpring Pharmaceutical Corporation
2.4.1 Business Overview
2.4.2 Motion Sickness Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Caleb Pharmaceuticals
2.5.1 Business Overview
2.5.2 Motion Sickness Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Myungmoon Pharm
2.6.1 Business Overview
2.6.2 Motion Sickness Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Myungmoon Pharm Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Baxter International
2.7.1 Business Overview
2.7.2 Motion Sickness Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Baxter International Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Reliefband Technologies
2.8.1 Business Overview
2.8.2 Motion Sickness Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Reliefband Technologies Motion Sickness Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Motion Sickness Treatment Market Competition, by Players
3.1 Global Motion Sickness Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Motion Sickness Treatment Players Market Share
3.2.2 Top 10 Motion Sickness Treatment Players Market Share
3.3 Market Competition Trend
4 Global Motion Sickness Treatment Market Size by Regions
4.1 Global Motion Sickness Treatment Revenue and Market Share by Regions
4.2 North America Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
5 North America Motion Sickness Treatment Revenue by Countries
5.1 North America Motion Sickness Treatment Revenue by Countries (2013-2018)
5.2 USA Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
6 Europe Motion Sickness Treatment Revenue by Countries
6.1 Europe Motion Sickness Treatment Revenue by Countries (2013-2018)
6.2 Germany Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
6.4 France Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Motion Sickness Treatment Revenue by Countries
7.1 Asia-Pacific Motion Sickness Treatment Revenue by Countries (2013-2018)
7.2 China Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
7.5 India Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
8 South America Motion Sickness Treatment Revenue by Countries
8.1 South America Motion Sickness Treatment Revenue by Countries (2013-2018)
8.2 Brazil Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Motion Sickness Treatment by Countries
9.1 Middle East and Africa Motion Sickness Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Motion Sickness Treatment Revenue and Growth Rate (2013-2018)
10 Global Motion Sickness Treatment Market Segment by Type
10.1 Global Motion Sickness Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Motion Sickness Treatment Market Forecast by Type (2018-2023)
10.3 Anticholinergic Revenue Growth Rate (2013-2023)
10.4 Antihistamines Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Motion Sickness Treatment Market Segment by Application
11.1 Global Motion Sickness Treatment Revenue Market Share by Application (2013-2018)
11.2 Motion Sickness Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Motion Sickness Treatment Market Size Forecast (2018-2023)
12.1 Global Motion Sickness Treatment Market Size Forecast (2018-2023)
12.2 Global Motion Sickness Treatment Market Forecast by Regions (2018-2023)
12.3 North America Motion Sickness Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Motion Sickness Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Motion Sickness Treatment Revenue Market Forecast (2018-2023)
12.6 South America Motion Sickness Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Motion Sickness Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Motion Sickness Treatment Picture
Table Product Specifications of Motion Sickness Treatment
Table Global Motion Sickness Treatment and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
